Related Experiment Video
Updated: May 12, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
RNA sequencing of cancer reveals novel splicing alterations
Jeyanthy Eswaran1, Anelia Horvath, Sucheta Godbole
1McCormick Genomic and Proteomics Center, The George Washington University, Washington, District of Columbia 20037, USA.
Abstract:
Breast cancer transcriptome acquires a myriad of regulation changes, and splicing is critical for the cell to "tailor-make" specific functional transcripts. We systematically revealed splicing signatures of the three most common types of breast tumors using RNA sequencing: TNBC, non-TNBC and HER2-positive breast cancer. We discovered subtype specific differentially spliced genes and splice isoforms not previously recognized in human transcriptome. Further, we showed that exon skip and intron retention are predominant splice events in breast cancer. In addition, we found that differential expression of primary transcripts and promoter switching are significantly deregulated in breast cancer compared to normal breast. We validated the presence of novel hybrid isoforms of critical molecules like CDK4, LARP1, ADD3, and PHLPP2. Our study provides the first comprehensive portrait of transcriptional and splicing signatures specific to breast cancer sub-types, as well as previously unknown transcripts that prompt the need for complete annotation of tissue and disease specific transcriptome.
Insights
This study reveals unique splicing patterns in triple-negative, non-triple-negative, and HER2-positive breast cancers. Researchers identified novel transcripts and splicing events critical for understanding breast cancer subtypes.
Area of Science:
- Molecular Biology
- Genomics
- Cancer Research
Background:
- Splicing is crucial for generating functional transcripts in cells.
- Breast cancer involves complex regulatory changes in gene expression.
Purpose of the Study:
- To systematically analyze splicing signatures across major breast cancer subtypes.
- To identify novel subtype-specific splice variants and deregulated transcriptional events.
Main Methods:
- RNA sequencing was employed to analyze transcriptomes of triple-negative (TNBC), non-TNBC, and HER2-positive breast cancers.
- Differential splicing analysis was performed to identify subtype-specific events.
Main Results:
- Subtype-specific differentially spliced genes and novel splice isoforms were discovered.
- Exon skipping and intron retention were identified as predominant splicing events.
- Differential primary transcript expression and promoter switching were significantly deregulated in breast cancer.
- Novel hybrid isoforms of key molecules (e.g., CDK4, LARP1) were validated.
Conclusions:
- This research provides a comprehensive view of transcriptional and splicing signatures specific to breast cancer subtypes.
- The identification of previously unknown transcripts highlights the need for updated transcriptome annotation in breast cancer.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
